Research output per year
Research output per year
Personal profile
Research interests
Dr. Korenblat performs patient based research in nonalcoholic fatty liver disease, portal hypertension and liver transplantation. His clinical practice is directed to the management of all forms of liver disease and liver transplant patients, with particular interest in nonalcoholic fatty liver disease, hepatocellular cancer, Wilson’s Disease and hereditary hemochromatosis.
Clinical interests
Liver diseases, fatty liver disease, viral hepatitis, liver transplantation, metabolic liver disease
Fingerprint
Dive into the research topics where Kevin Korenblat is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
Chin, R. I., Schiff, J. P., Bommireddy, A., Kang, K. H., Andruska, N., Price, A. T., Green, O. L., Huang, Y., Korenblat, K., Parikh, P. J., Olsen, J., Samson, P. P., Henke, L. E., Kim, H. & Badiyan, S. N., Jul 2023, In: Clinical and Translational Radiation Oncology. 41, 100627.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement from the American Heart Association
Kittleson, M. M., Sharma, K., Brennan, D. C., Cheng, X. S., Chow, S. L., Colvin, M., Devore, A. D., Dunlay, S. M., Fraser, M., Garonzik-Wang, J., Khazanie, P., Korenblat, K. M. & Pham, D. T., Aug 15 2023, In: Circulation. 148, 7, p. 622-636 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
REEF-1 Study Group, Sep 2023, In: The Lancet Gastroenterology and Hepatology. 8, 9, p. 790-802 13 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose
Chin, R. I., Bommireddy, A., Fraum, T. J., Ludwig, D. R., Huang, Y., Zoberi, J. E., Garcia-Ramirez, J. L., Maughan, N. M., Chapman, W., Korenblat, K., Henke, L. E., Kim, H. & Badiyan, S. N., Jul 1 2022, In: Advances in Radiation Oncology. 7, 4, 100948.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population-based retrospective cohort study
Afzal, A., Gage, B. F., Suhong, L., Schoen, M. W., Korenblat, K. & Sanfilippo, K. M., Jul 2022, In: Journal of Thrombosis and Haemostasis. 20, 7, p. 1610-1617 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations